FIELD: medicine, pharmaceutical industry, phytotherapy.
SUBSTANCE: invention proposes an agent used in treatment of infectious diseases. Agent used in treatment of infectious diseases comprises chitosan of polyfraction composition with amine groups of molecular mass from monomeric link - glucosamine to ˜350 kDa and deacetylation degree from ˜68 to ≤ 95% and vegetable raw aqueous extract chosen from the following group: Cetraria thallus, sage official herb, cocklebur leaves, black poplar buds, common wormwood herb, red roots, burdock roots, French honey-suckle herb, bur-marigold tripartite herb, sandy common immortelle flowers, dropwort elm-leaved flowers, river avens (Geum) roots, licorice glabrous roots, swampy sweet flag roots, burnet official roots,, nettle dioecious herb, swampy cudweed herb, common milfoil herb, sweet clover official herb, gum-free leaves, dropwort, willow bark, birch leaves, bilberry leaves, willow-herb narrow-leaves herb, peppermint herb, fenestrate Saint-John's-wort herb, knot-grass herb, shepherd's purse herb, violet pensy tricolor herb, speedwell herb, pot-marigold flowers, common tansy flowers, matricary official flowers, chicory roots, dandelion official roots, tormentil roots, cinnamon wild rose fruits, viburnum leaves, pinnate kalanchoe and maize stigmas. Aqueous extract is prepared by extraction of vegetable raw with demineralized water under definite conditions. Agent promotes to effective treatment of infectious diseases, such as chlamydiosis, herpes, erysipelas, viral hepatitis A and B, gastroenteric tract diseases, acute enteric infectious, and to declining period of clinical symptoms of diseases said.
EFFECT: valuable medicinal properties of agent.
10 cl, 2 dwg, 12 ex
Title | Year | Author | Number |
---|---|---|---|
BIOLOGICALLY ACTIVE FOOD SUPPLEMENT FOR PROPHYLAXIS AND THERAPY OF INFLAMMATION DISEASES | 2004 |
|
RU2270585C2 |
METHOD OF TREATMENT OF PATIENTS WITH INFECTIOUS DISEASES | 2000 |
|
RU2174000C1 |
METHOD FOR OBTAINING PHYTOCHITODESIS | 2001 |
|
RU2204402C2 |
METHOD OF TREATMENT OF PATIENTS WITH ONCOLOGICAL DISEASES | 1998 |
|
RU2165253C2 |
BRONCHIAL ASTHMA TREATMENT METHOD | 1998 |
|
RU2172634C2 |
AGENT FOR TREATMENT OF PATIENTS WITH HEPATITIS AND FIBROSIS SYMPTOMS | 2000 |
|
RU2164802C1 |
COMPOSITION WITH ANTINEOPLASTIC AND ADAPTOGENIC ACTIVITY (VERSIONS) AND BASED DRUG (VERSIONS) | 2009 |
|
RU2408383C1 |
MEDICATION FOR TREATMENT OF PATIENTS WITH DRUG HEPATITIS | 2009 |
|
RU2419449C1 |
METHOD OF COMPLEX TREATMENT OF CHRONIC VIRAL HEPATITISIS TYPES B AND C | 2007 |
|
RU2341275C1 |
AGENT FOR BODY CLEARANCE | 2001 |
|
RU2189247C1 |
Authors
Dates
2006-04-10—Published
2004-03-22—Filed